Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 238-242

  Pas, S ^a   Molenkamp, R ^b   Schinkel, J ^b   Rebers, S ^b   Copra, C ^a   Seven Deniz, S ^a   Thamke, D ^c   De Knegt, R J ^a   Haagmans, B L ^a   Schutten, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Roche Molecular Diagnostics Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DNA DETERMINATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSCRIPTION;

HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, VIRAL; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 84871705545     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01729-12     Document Type: Article

References (16)

1. de Bruijne J, Schinkel J, Prins M, Koekkoek SM, Aronson SJ, van Ballegooijen MW, Reesink HW, Molenkamp R, van de Laar TJ. 2009. Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J. Clin. Microbiol. 47:3832-3838.
2. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F. 2011. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 31:61-80.
3. Gorrin G, Friesenhahn M, Lin P, Sanders M, Pollner R, Eguchi B, Pham J, Roma G, Spidle J, Nicol S, Wong C, Bhade S, Comanor L. 2003. Performance evaluation of the VERSANT HCV RNA qualitative assay by using transcription-mediated amplification. J. Clin. Microbiol. 41 : 310-317. (Pubitemid 36098593)
4. Hendricks DA, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L. 2003. Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J. Clin. Microbiol. 41:651-656. (Pubitemid 36184177)
5. Sarrazin C, Dragan A, Gartner BC, Forman MS, Traver S, Zeuzem S, Valsamakis A. 2008. Evaluation of an automated, highly sensitive, realtime PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA. J. Clin. Virol. 43:162-168.
6. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, Zadak M, Babiel R. 2007. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J. Clin. Virol. 38:326-333. (Pubitemid 46414003)
7. Schutten M, Niesters HG. 2001. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev. Mol. Diagn. 1:153-162. (Pubitemid 34662824)
8. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. 2007. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hepatology 46:22-31. (Pubitemid 47171917)
9. Colucci G, Ferguson J, Harkleroad C, Lee S, Romo D, Soviero S, Thompson J, Velez M, Wang A, Miyahara Y, Young S, Sarrazin C. 2007. Improved COBAS TaqMan hepatitis C virus test (version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study. J. Clin. Microbiol. 45:3595-3600. (Pubitemid 350156854)
10. Kleiber J, Walter T, Haberhausen G, Tsang S, Babiel R, Rosenstraus M. 2000. Performance characteristics of a quantitative, homogeneous Taq-Man RT-PCR test for HCV RNA. J. Mol. Diagn. 2:158-166.
11. Vermehren J, Colucci G, Gohl P, Hamdi N, Abdelaziz AI, Karey U, Thamke D, Zitzer H, Zeuzem S, Sarrazin C. 2011. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity. J. Clin. Microbiol. 49:3309-3315.
12. Noppornpanth S, Sablon E, De Nys K, Truong XL, Brouwer J, Van Brussel M, Smits SL, Poovorawan Y, Osterhaus AD, Haagmans BL. 2006. Genotyping hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5′ untranslated regions. J. Clin. Microbiol. 44:3969-3974. (Pubitemid 44737237)
13. Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. 2007. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J. Clin. Microbiol. 45:1102-1112. (Pubitemid 46626471)
14. Jennings C, Harty B, Granger S, Wager C, Crump JA, Fiscus SA, Bremer JW. 2012. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J. Clin. Microbiol. 50:2737-2747.
15. Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. 2011. Management of hepatitis C virus genotype 4: recommendations of an international expert panel. J. Hepatol. 54:1250-1262.
16. Ross RS, Viazov SO, Hoffmann S, Roggendorf M. 2001. Performance characteristics of a transcription-mediated nucleic acid amplification assay for qualitative detection of hepatitis C virus RNA. J. Clin. Lab. Anal. 15:308-313. (Pubitemid 33097025)